India is one of the few countries in the world to have isolated the novel coronavirus that causes Covid-19. Now, it is on track to develop one of the cheapest vaccines, according to Dr. M V Padma Srivastava, chief of neurosciences at All India Institute of Medical Sciences (AIIMS).

(People Also Like To Read: 9 Simple And Best Skin And Hair Care Tips During Winters)

Last week, Dr. Srivastava volunteered for the third phase of the trial for Covaxin, an indigenous vaccine developed by the Indian Council of Medical Research (ICMR) in collaboration with Bharat Biotech. “I was the first to receive the Covaxin shot in AIIMS, Delhi, last Thursday,”. Another shot will be given after 28 days.”

The 55-year-old doctor added that she had not suffered any side-effects after the administration of the vaccine. Recently, there was a controversy when a participant in a test for another Covid-19 vaccine claimed to have had severe side-effects.

AIIMS plans to enroll more than 1,000 volunteers for the third phase of the Covaxin trials. Sources said 40-50 volunteers have already registered and have even received the first shot of the indigenous Covid vaccine.

“The third phase of the trials will have more than 26,000 participants across the country. It is the most important stage of trials and comes before the vaccine can be used to immunize people against the viral infection that has been plaguing the world for nearly nine months,” disclosed a senior doctor in the community medicine department of AIIMS. The doctor also revealed that the first and second phases of the trials for Covaxin had been completed and that it had been well tolerated by the test participants.

(You Might Also Like To Read: Know The Treatment And Symptoms Of Fibromyalgia)

Source: Economic Times